An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease (SHIELD-4)

07/11/2013

Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Massachusetts, Michigan, Minnesota, Missouri, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Utah, Virginia, Wisconsin, Australia, Austria, Belgium, Chile, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Netherlands, New Zealand, Poland, Portugal, Russia, Slovakia, South Korea, Spain, Switzerland, Taiwan, Ukraine, United Kingdom. clinicaltrials.gov

Published in Brief:

SmartBrief Job Listings for Health Care